About Index Trending news
Analyze
Top 50 Pricing
Neuraltus Pharmaceuticals

Neuraltus Pharmaceuticals

Work at Neuraltus Pharmaceuticals? Add yourself to this profile

Neuraltus Pharmaceuticals

Neuraltus Pharmaceuticals is focused on developing therapeutics that meetcritical unmet needs in treating neurodegenerative diseases.

Elsewhere

Alexa global traffic share

24 May 2016
$14,940,000
Venture capital (Series UNDISCLOSED)

SEC FORM D

sec
01 Apr 2012
$1,501,000
Venture capital
Adams Street Partners, Latterell Venture Partners
31 Jan 2012
$9,600,000
Venture capital (Series B)
26 Mar 2009
$17,000,000
Venture capital (Series A)